Permira, the global investment firm, and PharmaCord LLC (“PharmaCord”), a leading provider of patient services for the pharmaceutical industry, announce that a company backed by the Permira funds has signed a definitive agreement to make a substantial investment in PharmaCord. PharmaCord is a high-growth pharma services company that serves as a commercialization partner for life sciences organizations with the goal of enhancing the patient experience. A leading tech-enabled player in the space, PharmaCord has relationships with over 30 pharmaceutical company clients and supports over 100 pharmaceutical products through its various programs.
Read the full article: Permira Announces Substantial Investment in PharmaCord //
Source: https://www.businesswire.com/news/home/20240605561114/en/Permira-Announces-Substantial-Investment-in-PharmaCord